A paclitaxel-eluting stent for the prevention of coronary restenosis

New England Journal of Medicine

Volumn 348, Issue 16, 2003, Pages 1537-1545

  Park, Seung Jung ^a   Shim, Won Heum ^b   Ho, David S ^c   Raizner, Albert E ^d   Park, Seong Wook ^a   Hong, Myeong Ki ^a   Lee, Cheol Whan ^a   Choi, Donghoon ^b   Jang, Yangsoo ^b   Lam, Ricky ^c   Weissman, Neil J ^e   Mintz, Gary S ^f  

^a Asan Medical Center   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d Cardiovasc Angiography Anal Lab   (United States)

^e WASHINGTON HOSPITAL CENTER   (United States)

^f CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; HEPARIN; PACLITAXEL; RAPAMYCIN; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY STENT; DEATH; DOSE RESPONSE; DRUG SAFETY; FEMALE; HEART INFARCTION; HUMAN; IMPLANTATION; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; THROMBOSIS; TRIPLE BLIND PROCEDURE;

ANGIOGENESIS INHIBITORS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; STENTS; TICLOPIDINE; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0037451926     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa021007     Document Type: Article

References (28)

1. Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 2002; 39:183-93.
2. Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 1996;94:1247-54.
3. Hanke H, Kamenz J, Hassenstein S, et al. Prolonged proliferative response of smooth muscle cells after experimental intravascular stenting. Eur Heart J 1995;16:785-93.
4. Moreno PR, Palacios IF, Leon MN, Rhodes J, Fuster V, Fallon JT. Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. Am J Cardiol 1999;84:462-6.
5. Weissman NJ, Wilensky RL, Tanguay JF, et al. Extent and distribution of in-stent intimal hyperplasia and edge effect in a non-radiation stent population. Am J Cardiol 2001; 88:248-52.
6. de Feyter PJ, Vos J, Rensing BJ. Antirestenosis trials. Curr Interv Cardiol Rep 2000;2:326-31.
7. Morice M-C, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimuseluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
8. Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001;104:2007-11.
9. Rensing BJ, Vos J, Smits PC, etal. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasound follow-up. Eur Heart J 2001;22:2125-30.
10. Shiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by Taxol. Nature 1979;277:665-7.
11. Rowinsky EK, Cazenave LA, Donehower RC. Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 1990;82:1247-59.
12. Rowinski EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC. Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 1993;20:Suppl 3:1-15.
13. Rowinsky EK, Donehower RC. Paclitaxel (Taxol). N Engl J Med 1995;332:1004-14. [Erratum, N Engl J Med 1995;333:75.]
14. Axel DI, Kunert W, Göggelmann C, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997;96:636-45.
15. Heldman AW, Cheng L, Jenkins GM, et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 2001;103:2289-95.
16. Herdeg C, Oberhoff M, Baumbach A, et al. Local paclitaxel delivery for prevention of restenosis: biological effects and efficacy in vivo. J Am Coll Cardiol 2000;35:1969-76.
17. Sollott SJ, Cheng L, Pauly KK, et al. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest 1995;95:1869-76.
18. Yoon Y, Shim WH, Lee DH, et al. Usefulness of cilostazol versus ticlopidine in coronary artery stenting. Am J Cardiol 1999;84:1375-80.
19. Park SW, Lee CW, Kim HS, et al. Comparison of cilostazol versus ticlopidine therapy after stent implantation. Am J Cardiol 1999;84:511-4.
20. Park SW, Lee CW, Kim HS, et al. Effects of cilostazol on angiographic restenosis after coronary stent placement. Am J Cardiol 2000;86:499-503.
21. Kuntz RE, Safian RD, Carrozza JP, Fishman RF, Mansour M, Baim DS. The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting. Circulation 1992;86:1827-35.
22. Condado JA, Waksman R, Calderas C, Saucedo J, Lansky A. Two-year follow-up after intracoronary gamma radiation therapy. Cardiovasc Radiat Med 1999;1:30-5.
23. Teirstein PS, Massullo V, Jani S, et al. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2000;101:360-5.
24. Kimura T, Abe K, Shizuta S, et al. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation 2002;105:2986-91.
25. Lee JH, Lee CW, Park SW, et al. Long-term follow-up after deferring angioplasty in asymptomatic patients with moderate noncritical in-stent restenosis. Clin Cardiol 2001;24:551-5.
26. Ormiston JA, Stewart FM, Roche AH, Webber BJ, Whitlock RM, Webster MW. Late regression of the dilated site after coronary angioplasty: a 5-year quantitative angiographic study. Circulation 1997;96:468-74.
27. Hermiller JB, Fry ET, Peters TF, et al. Late coronary artery stenosis regression within the Gianturco-Roubin intracoronary stent. Am J Cardiol 1996;77:247-51.
28. Farb A, Heller PF, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 2001;104:473-9.